ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular Pharmaceutics

• Publication date

  2010-04-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/mp900306xPMID 20230014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

  2009cited by this paper
• Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

  2009cited by this paper
• Acteoside protects human neuroblastoma SH-SY5Y cells against beta-amyloid-induced cell injury.

  2009cited by this paper
• Potential protection of curcumin against amyloid beta-induced toxicity on cultured rat prefrontal cortical neurons.

  2009cited by this paper
• Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study.

  2009cited by this paper
• Concentration dependent antioxidant/pro-oxidant activity of curcumin studies from AAPH induced hemolysis of RBCs.

  2008cited by this paper
• Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation.

  2008cited by this paper
• Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications.

  2007cited by this paper
• Bioavailability of curcumin: problems and promises.

  2007cited by this paper
• Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.

  2007cited by this paper
• Transferrin‐conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain

  2007cited by this paper
• Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo*

  2005cited by this paper
• Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention.

  2005cited by this paper
• Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.

  2005cited by this paper
• Stability-indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations.

  2005cited by this paper
• Protective effect of tubuloside B on TNFalpha-induced apoptosis in neuronal cells.

  2004cited by this paper
• Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro

  2004cited by this paper
• Drugs Targeting Alzheimer's Disease: Some Things Old and Some Things New

  2003cited by this paper
• Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

  2003cited by this paper
• The low-density lipoprotein receptor gene family: a cellular Swiss army knife?

  2002cited by this paper
• Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier

  2002cited by this paper
• Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.

  2002cited by this paper
• Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner.

  2002cited by this paper
• The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease.

  2000cited by this paper
• Flow cytometry of apoptotic cell death.

  2000cited by this paper
• Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader.

  1999cited by this paper
• Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.

  1999cited by this paper
• Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis.

  1999cited by this paper
• Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.

  1998cited by this paper
• Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta.

  1997cited by this paper
• Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease.

  1997cited by this paper
• Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.

  1997cited by this paper
• Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells.

  1996cited by this paper
• Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides

  1996cited by this paper
• Red wine and antioxidant activity in serum.

  1994cited by this paper
• Vitamin E protects nerve cells from amyloid beta protein toxicity.

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Brain targeted drug delivery using liposomes and polymeric nanocarriers: Pharmaceutical and preclinical perspectives in Alzheimer's and Parkinson's disease

  2026cites this paper
• Nanotechnology-Based Herbal Medicine: Preparation, Synthesis, and Applications in Food and Medicine

  2025cites this paper
• Engineered nanoplatforms for brain-targeted co-delivery of phytochemicals in Alzheimer's disease: Rational design, blood-brain barrier penetration, and multi-target therapeutic synergy

  2025cites this paper
• Curcumin Delivery in Regenerative Medicine for Alzheimer’s Disease

  2025cites this paper
• Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells

  2024cites this paper
• Herbal nanoparticles: a targeted approach for neurodegenerative disorder treatment

  2024cites this paper
• Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review.

  2024cites this paper
• Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer's Diseases.

  2024cites this paper
• Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer's disease.

  2024cites this paper
• Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases

  2024cites this paper
• Recent advances in therapeutic strategies for Alzheimer's and Parkinson's disease using protein/peptide co‐modified polymer nanoparticles

  2024cites this paper
• Polyphenols and Their Biogenic Nano-Formulations Targeting BACE1 as Anti-Amyloid Therapies; Meeting the Challenges of Bioavailability, Safety, and Specificity for the Treatment of Alzheimer's Disease.

  2024cites this paper
• Green synthesis of nanoparticles using medicinal plants as an eco-friendly and therapeutic potential approach for neurodegenerative diseases: a comprehensive review

  2024cites this paper
• Biopolymers as promising vehicles for drug delivery to the brain

  2023cites this paper
• Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.

  2023cites this paper
• ApoE—functionalization of nanoparticles for targeted brain delivery—a feasible method for polyplexes?

  2023cites this paper
• Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives

  2023cites this paper
• Adverse Effects of Non-Metallic Nanoparticles in the Central Nervous System

  2023cites this paper
• Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers

  2023cites this paper
• Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine.

  2023cites this paper
• A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics

  2023cites this paper
• Rationally designed cyclic peptides and nanomaterials as ‘next-generation’ anti-amyloid therapeutics

  2023cites this paper
• Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders

  2023cites this paper
• Strategic nanocarriers to control neurodegenerative disorders: concept, challenges, and future perspective.

  2023cites this paper
• Impact of nanoparticles on amyloid β-induced Alzheimer’s disease, tuberculosis, leprosy and cancer: a systematic review

  2023cites this paper
• Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease

  2022cites this paper
• Nanoparticles-based anti-aging treatment of Alzheimer’s disease

  2022cites this paper
• Ameliorating potential of curcumin and its analogue in central nervous system disorders and related conditions: A review of molecular pathways

  2022cites this paper
• Nanotechnology: A Promising Targeted Drug Delivery System for Brain Tumours and Alzheimer's Disease.

  2022cites this paper
• Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles, and nano-bodies.

  2021cites this paper
• Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease

  2021cites this paper
• A comprehensive review of the therapeutic potential of curcumin nanoformulations

  2021cites this paper
• Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis.

  2021cites this paper
• Advancements in delivery of herbal drugs for cognitive disorders

  2021cites this paper
• Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders.

  2021cites this paper
• Bio-nano Interface and Its Potential Application in Alzheimer’s Disease

  2021cites this paper
• Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology

  2021cites this paper
• Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

  2021cites this paper
• Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

  2020cites this paper
• Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases

  2020cites this paper
• Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment

  2020cites this paper
• Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity.

  2020cites this paper
• Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer's Disease.

  2020cites this paper
• From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain Barrier

  2020cites this paper
• Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics

  2020cites this paper
• Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics

  2020cites this paper
• Herbal Nanocarriers for Cancer Therapy

  2020cites this paper
• Nanomedicine against Alzheimer's and Parkinson's disease.

  2020cites this paper
• Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review

  2020cites this paper
• Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders

  2020cites this paper
• The Strategies of Nanomaterials for Therapy

  2019cites this paper
• Photo-triggered Drug Delivery Systems for Neuron-related Applications.

  2019cites this paper
• Neurotheranostics as personalized medicines.

  2019cites this paper
• Comparison between Polybutylcyanoacrylate Nanoparticles with Either Surface-Adsorbed or Encapsulated Brain-Derived Neurotrophic Factor on the Neural Differentiation of iPSCs

  2019cites this paper
• Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.

  2019cites this paper
• Formulations of Curcumin Nanoparticles for Brain Diseases

  2019cites this paper
• Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease.

  2019cites this paper
• Carbon nanomaterials and amyloid‐beta interactions: potentials for the detection and treatment of Alzheimer's disease?

  2019cites this paper
• Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy.

  2019cites this paper
• Mitochondria-Targeted Nanoparticles

  2019cites this paper
• Curcumin- and Fish Oil-Loaded Spongosome and Cubosome Nanoparticles with Neuroprotective Potential against H2O2-Induced Oxidative Stress in Differentiated Human SH-SY5Y Cells

  2019cites this paper
• Neuroprotective Propensity of Curcumin: Evidence in Animal Models, Mechanisms, and Its Potential Therapeutic Value

  2019cites this paper
• Curcumin: Historical Background, Chemistry, Pharmacological Action, and Potential Therapeutic Value

  2019cites this paper
• Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery

  2019cites this paper
• A Bird’s-Eye View of the Multiple Biochemical Mechanisms that Propel Pathology of Alzheimer’s Disease: Recent Advances and Mechanistic Perspectives on How to Halt the Disease Progression Targeting Multiple Pathways

  2019cites this paper
• Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.

  2019cites this paper
• Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds

  2019cites this paper
• Nano-engineering Nanoparticles for Clinical Use in the Central Nervous System: Clinically Applicable Nanoparticles and Their Potential Uses in the Diagnosis and Treatment of CNS Aliments

  2019cites this paper
• Augmentation of therapeutic potential of curcumin using nanotechnology: current perspectives

  2018influential citation
• Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders

  2018cites this paper
• Therapeutic nanoplatforms and delivery strategies for neurological disorders

  2018cites this paper
• Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation

  2018cites this paper
• Synthesis and characterization of alkylated caseinate, and its structure-curcumin loading property relationship in water.

  2018cites this paper
• Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule?

  2017influential citation
• Targeted Nanoparticles for the Treatment of Alzheimer's Disease.

  2017cites this paper
• Curcumin reduces hippocampal neuron apoptosis and JNK-3 phosphorylation in rats with Aβ-induced Alzheimer's disease: protecting spatial learning and memory

  2017cites this paper
• Nanoformulations of curcumin: an emerging paradigm for improved remedial application

  2017cites this paper
• Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates.

  2017cites this paper
• Stratagems of Nanotechnology Augmenting the Bioavailability and Therapeutic Efficacy of Traditional Medicine to Formulate Smart Herbal Drugs Combating

  2017cites this paper
• Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.

  2017cites this paper
• Curcumin as fluorescent probe for directly monitoring in vitro uptake of curcumin combined paclitaxel loaded PLA-TPGS nanoparticles

  2016cites this paper
• Encapsulation of curcumin in polyelectrolyte nanocapsules and their neuroprotective activity

  2016cites this paper
• Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile.

  2016cites this paper
• Targeted Delivery of Nutraceuticals Using Nanoparticles

  2016cites this paper
• Exploring the use of nanocarrier systems to deliver the magical molecule; Curcumin and its derivatives.

  2016cites this paper
• Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain.

  2016cites this paper
• Recent trends in nano-based drug delivery systems for efficient delivery of phytochemicals in chemotherapy

  2016cites this paper
• Metabolites Identification of Curcumin,Demethoxycurcumin and Bisdemethoxycurcuminin Rats After Oral Administration of NanoparticleFormulations by Liquid Chromatography Coupledwith Mass Spectrometry

  2016cites this paper
• Potential use of nanomedicines for drug delivery across the BBB in health and diseased brain.

  2016cites this paper
• Multifunctional Curcumin-Nanocarriers Based on Host-Guest Interactionsfor Alzheimer Disease Diagnostic

  2015cites this paper
• Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systems

  2015cites this paper
• Therapeutic Applications of Curcumin Nanoformulations

  2015cites this paper
• Targeted nanoparticles in mitochondrial medicine.

  2015cites this paper
• Targeted Drug Delivery : Concepts and Design

  2015cites this paper
• Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo

  2015cites this paper
• Effect of polymer architecture on curcumin encapsulation and release from PEGylated polymer nanoparticles: Toward a drug delivery nano-platform to the CNS.

  2015cites this paper
• Nanotoxicology: Contemporary Issues and Future Directions

  2015cites this paper
• Nanoparticles for Diagnosis and/or Treatment of Alzheimer's Disease

  2014cites this paper
• Nanotechnology and Alzheimer's disease: what has been done and what to do.

  2014cites this paper
• Nanomedicine Based Drug Targeting in Alzheimer’s Disease: High Impact of Small Carter

  2014cites this paper